Product Approved / Norland Corp / The New Zealand Guidelines Group / Patient Total / Ligand / MBS Resources / Expert Group / Inderlec Medical Systems Pty Ltd / Cytyc Australia Pty Ltd / GE Medical Systems GE Medical Systems Australia Pty Ltd / GP / TBA Resources / Hologic Inc / MTF Figure 2 Current / Medlink Inderlec Medical Systems Pty Ltd / Coleman / /
Continent
Australia / /
Country
Australia / /
Currency
USD / /
Facility
hospital Costs / Australian Institute of Health / Pharmacy Private Unknown Variable** / The Royal Australian College of General Practitioners / /
IndustryTerm
clinical management algorithms / fracture risk assessment tools / fracture determinant tools / treatment of osteoporosis / Cancer Treat / draft protocol / treatment for breast cancer / final protocol / clinical management / pharmaceutical / decision analytic protocol / breast cancer treatment / food / energy / date manufacturer / pharmaceuticals / healthcare system / health insurer / absorptiometry device / treatment of breast cancer / treatment for hormone receptor-positive breast cancer / dual-energy x-ray imaging / clinical management algorithm / healthcare resource information / lifestyle management / healthcare resources / draft decision analytic protocol / therapies for hormone receptor positive breast cancer / dual-energy / existing fracture risk assessment tools / /
MedicalCondition
Female hypogonadism / rheumatoid arthritis / carcinoma / primary hyperparathyroidism / premature menopause / Skeletal metastases / malabsorbtive disorder / hypogonadism / renal disease / Bone resorption / liver disease / breast cancer / e.g. pneumonia / well defined disease / Osteopenia / malabsorptive disorders / Intervention Description Osteoporosis / osteoporosis DXA / Cancer / hormone receptor positive breast cancer / disease / Chronic liver disease / Chronic / hypogonadism Primary hyperparathyroidism Chronic / Male hypogonadism / diseases / osteoporosis / Primary hyperparathyroidism Chronic / disorders / skeletal disorder / /
Australian College / World Health Organization / Medicare / DAP PASC / Australian and New Zealand Bone and Mineral Society / Australian Institute of Health and Welfare / Department of Health / Medical Services Advisory Committee / /
Person
Ray Absorptiometry / /
Position
general practitioner / Commonwealth Minister / physician / consultant physician / device Technician / General / technician / Governor / Government Health Minister / /
1313 Final protocol to guide the assessment of bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment July 2013